GuruFundPicks.com offers top buy & sell picks based on the collective or Consensus Picks' of over 330 of our hand-picked top hedge & mutual fund managers, incl. 78 legendary or guru fund managers, 27 of the world's largest or mega funds, 165 sector-focused funds (in gold, biotech, tech, energy, consumer, finance & REITs), 59 billionaires, 54 new masters and 40 tiger, 52 shareholder activist and our Winners Circle Top 100 Performing Hedge Fund Managers (updated quarterly). We offer market-beating tools and services including Consensus Picks' DIY Tools, Top 20 Small-Cap and Top 30 All-Cap Long/Short Newsletters based on the Consensus Picks system, and Trade Alert Services for Self & Auto-Trading. All of our services have beaten market averages by wide margins. See our website GuruFundPicks.com for the latest performance numbers, or contact us at support@GuruFundPicks.com.
The two authors are co-managers of a family partnership long/short equity fund since 2001, that have a successful track record in trading primarily small-cap aggressive growth companies based on a fundamental valuation analysis of current news, including quarter reports, guidance, biotech clinical study results and other news. The junior partner is a self-taught private investor with a Business degree from the New York University's Leonard N. Stern School of Business and the senior partner has an MBA from the University of Virginia Darden School of Business, including prior MS & BS (Engg.) degrees, and with experience in business strategy consulting to large fortune 100 companies.
We are generally sector and market-cap agnostic, identifying opportunities using a 'stock picking' bottom-up, fundamentals-based, valuation-driven approach. However, we find most opportunities in the small-cap space, in technology & healthcare sectors, with some also found often in the consumer, energy & basic materials sectors.
Follow us on Seeking Alpha and Twitter (@GuruFundPicks), and connect with us on LinkedIn (http://www.linkedin.com/in/manishbabla)
EP Vantage is a forward-looking comment and analysis service tailored to the needs of pharma and finance professionals, focusing on the events that will define the future of companies, products and therapy areas. Written by experienced journalists, EP Vantage provides timely financial analysis of regulatory and patent decisions, marketing approvals, licensing deals, and M&A, giving fresh angles and insight to both current and future industry triggers. EP Vantage is powered by EvaluatePharma, the industry leader in consensus forecasts.
I currently work in the health care field. I am a long-term investor who conducts extensive research as part of my due diligence when considering a stock. My articles hope to provide unbiased background information to help others make an educated decision.
Although I recommend a diversified portfolio, I have a special interest in biomedical firms. Since biomedical investing is often very risky, I believe that research is especially important when investing in this industry. I find biomedical investing rewarding because these investments may not only yield high returns but also help save lives.
Bill Gunderson @billgunderson is the CEO and Chief Market Strategist of Gunderson Capital Managment in San Diego, CA.
He is also a professional money manager, former research analyst, author of Best Stocks Now, and developer of the Best Stocks Now smartphone app.
He offers four free weeks to his weekly Best Stocks Now to Seeking Alpha readers at gundersoncapital.com
He also hosts a daily stock market radio show that is syndicated nationwide on the Salem Broadcast Network.
Bill has appeared on the Fox Business Channel and on Bloomberg Radio numerous times .His articles have been published in Barron's, Forbes, TheStreet.com and numerous other publications.
He can be reached at firstname.lastname@example.org or by calling (855)611-BEST.
Andrew McDonald is a healthcare investment professional with expertise in identifying transformative medicines as well as in forecasting clinical trial, regulatory, and sales outcomes. Prior to co-founding LifeSci Advisors, Andrew most recently served as senior biotechnology analyst at Great Point Partners, a dedicated life science hedge fund. From 2004-2006, Andrew was Co-head of Healthcare Research and Biotechnology Analyst at ThinkEquity Partners, a boutique investment bank. Prior to entering the financial services industry, Andrew was a medicinal chemist at Cytokinetics from 2001-2004, where he discovered and developed a promising anti-cancer agent now in clinical trials. Andrew began his pharmaceutical career as a medicinal chemist at Pfizer from 2000-2001. Andrew received a Ph.D. in organic chemistry from UC Irvine and completed his B.S. in chemistry at UC Berkeley.
I am a semi-retired investor mainly trading equities & bonds. Most of my career was spent as an investment analyst in the front office of a private banking house In Geneva. Prior to that I worked for the Emerging Markets desk of a major banking house in London. Now that I'm retired, I write mainly about my lifelong interest, which is science and biology. I now live in Cyprus, on the periphery of the EU taking up the financial chaos from all sides.
Author of the critically acclaimed book, "Taking Charge With Value Investing (McGraw-Hill, 2013)" and the equity research company "BNL Finance". An analyst that ranks in the top 4% on both tipranks.com and Motley Fool CAPS for stock picking performance.
Stephen Aniston is an investment advisor who focuses on the CBOE VIX futures market and related exchange traded products. He runs VIXCONTANGO.com - the best investment analysis service of the VIX futures market and is a sub-advisor to MRPAX, a managed short volatility mutual fund. Before becoming an investment advisor, Mr. Aniston was a technology manager and software architect with over 10 years of experience in the financial industry. He was Technical Architect for the Merchant Bank at Goldman Sachs and Technology Vice President for the Investment Bank at the Royal Bank of Scotland. He also had stints at hedge fund investment firms (commonly called fund-of-funds) K2 Advisors and Ivy Asset Management. He graduated from Stanford University with an engineering degree in the late 90s
Tom Lydon is editor and publisher of ETF Trends, a website with daily news and commentary about the fast-changing trends in the exchange traded fund (ETF) industry. Mr. Lydon is also CEO of Global Trends Investments, an investment advisory firm specializing in the creation of customized portfolios for high-net worth individuals. He has been involved in money management for more than 25 years. Mr. Lydon serves on the Board of Directors for U.S. Global Investors, Inc. and Guggenheim Investments. In early 2010, Mr. Lydon helped create the CNBC Model ETF Portfolios. Mr. Lydon is the author of The ETF Trend Following Playbook, as well as iMoney: Profitable Exchange-Traded Fund Strategies for Every Investor. He is Co-Founder of Virtual Summits, educational virtual events for financial advisors.
Visit his site: ETF Trends (http://www.etftrends.com/)
The ETF Virtual Summit is the largest exchange traded fund (ETF) investment conference in the world. ETF Trends and RIA Database host this complimentary, interactive conference that exists completely online. The virtual showroom features keynote speakers, panel webinars, an exhibitor hall, a networking lounge and hot topic forums. Designed exclusively for Financial Advisors, this conference allows you to interact with experts in the ETF industry in a unique, virtual environment, avoiding the hassles and costs of traveling. Details on the conference, including agenda, past attendee statistics and sponsor information can be found at www.ETFVirtual.com.
The Alts Virtual Summit is the leading Alternative Investment conference for financial advisors. ETF Trends and RIA Database host this complimentary, interactive conference that exists completely online. The virtual showroom features keynote speakers, panel webinars, an exhibitor hall, a networking lounge and hot topic forums. Designed exclusively for Financial Advisors, this conference allows you to interact with experts in the Alternative Investment industry in a unique, virtual environment, avoiding the hassles and costs of traveling. Details on the conference, including agenda, past attendee statistics and sponsor information can be found at www.AltsVirtual.com.
John Hodge is an active trader who follows the technology/biotech sector specifically. I have been successfully trading stocks for the last 16 years and still thank those that pointed me in the direction of Qualcomm and Amgen many years ago. I believe research and timing is the key to long term goal attainment in the market.
Bill is Chief Investment Officer of Luby Asset Management LLC, an investment management company in Tiburon, California. He also publishes the VIX and More (http://vixandmore.blogspot.com/) blog and an investment newsletter. His research and trading interests focus on volatility, market sentiment, technical analysis, ETPs and options. Bill was previously a business strategy consultant. When not trading or blogging, he can often be found running, hiking, and kayaking in Northern California. Bill has a BA from Stanford University and an MBA from Carnegie-Mellon University. Visit Bill's blog, VIX and More (http://vixandmore.blogspot.com/)
The enormous advancement in the biological sciences that is taking place has begun to change the traditional way of practicing medicine. Far-reaching biological products are being approved and news about breakthroughs are occupying the media headlines. However, selecting the biotechnology firms for investment requires not only an understanding of the company's finances, but also deep knowledge of the company's potential and the potential and scientific validity of it's products and technologies.
Our Mission is evaluating biotechnology companies, their products, their technologies, scientists, managements, as well as their finances. Our goal is to impart our readers with the knowledge and insight so that they may have a heightened understanding and appreciation for the biotechnology industry.
The Prohost Letter has been in circulation since 1992. Our readers are comprised of venture capital, fund managers, investors, medical professionals and individuals with one common interest, biotechnology.
Prohost Letter is posted in the members areas on the www.prohostbiotech.com. around 40 times a year. Articles are posted several times a week for subscribers in TODAY'S HIGHLIGHTS section and in News & Comments sector for all website visitors
Alex Daley is the senior editor of Casey’s Extraordinary Technology. In his varied career, he’s worked as a senior research executive, a software developer, project manager, senior IT executive, and technology marketer.
He’s a technologist who has collaborated on the development of cutting-edge technologies, including: remote lie detectors that work invisibly across a room, autonomous/robotic vehicles that can drive themselves unaided across hundreds of miles of rugged desert terrain, computer vision systems that enable computers to understand the depth in 2D photographs, lightweight composite ceramics that can withstand artillery fire better than metal, maps of the human genome, automated analysis of video for non-verbal communication cues, and face detection and recognition for spotting people in photos and surveillance videos.
But Alex’s technological experience is only half the story. He’s an industry insider of the highest order, having been involved in numerous startups as an advisor to venture capital companies. He’s a trusted advisor to the CEOs and strategic planners of some of the world’s largest tech companies. And he’s a successful angel investor in his own right, with a long history of spectacular investment successes.
I am a market enthusiast and part-time trader. I started writing for Seeking Alpha in 2011, and it has been a tremendous opportunity and learning experience. I have been interested in the markets since elementary school, and hope to pursue a career in the investment management industry. I have been active in the markets for several years, and am primarily focused on long/short equities.
I hold a Bachelor of Science Degree from Lehigh University, where I double majored in Finance and Accounting, with a minor in History. My major track focused on Investments and Financial Analysis. While at Lehigh, I was the Head Portfolio Manager of the Investment Management Group, a student group that manages three portfolios, one long/short and two long only. I have had two internships, one a summer internship at a large bank, and another helping to manage the Lehigh University Endowment for nearly a year.
Disclaimer: Bill reminds investors to always due their own due diligence on any investment, and to consult their own financial adviser or representative when necessary. Any material provided is intended as general information only, and should not be considered or relied upon as a formal investment recommendation.
Back in the deep forests of the southern Adirondacks after a six month, 9000 miles bicycle tour. When was the last time YOU went on a six month vacation that cost you about $100 a week. Most of that was for food; and I STILL MANAGED to trim down to 175lbs.Healthy and happy here, ready to get back to the market and writing for SA.
Now you know how I can live on an income most of you call pocket change. Put me in the bottom 1% of Seeking Alpha readers and most certainly contributors. Nothing like hanging out with loggers to cut expenses.
What a great way to avoid the carping on Wall Street. If I read another article about how the market is in a bubble, I shall pull out my hair...which is difficult because I have a shaved head.
Seriously though, I am a tried, true, and original Investment Biker. I've already toured in Europe, Asia, North and South America (see my website below) so I have about 200,000 cycling miles under my belt. It's been a while since I've done a long tour so starting this spring of 2015 I'm hittin' the road with my 28 speed Fuji Touring bike and riding for as long as I want. (Sorry about the Jap bike for all you Harley guys). Think about it...since I usually 'wild camp' in the forests for nothing, my only real expenses are food and some routine maintenance. I cover those expenses by using the monthly options cycle to generate income from calls, puts, or spreads of various sorts. So while you Seeking Alpha trendies are sitting in front of your screens all day, I'll be out riding in the Sierra, the Cascades, the Rockies, the Appalachians, the Catskills, the Adirondacks, the Green and White Mountains...and thats just this summer!
All i need to keep an eye on the markets are a small Grundig AM/FM/Shortwave radio (go to hell you Sirius guys!) and a Netbook for trading and fun when I can get internet access...which last time I looked was everywhere.
Enjoy the bull market which started in Summer of 2009 and should run for a few more years. Ignore these 'stuck in a rut guys' and Obamanazis. Between lower energy prices from natural gas frackomania, lower medical costs and longer lifespans from bioengineering marvels just coming down the pike, and the eventual collapse of slave labor kleptocracies like China (and Chicago), the outlook for stocks and capitalism is as strong as its ever been.
When not cycling I am a self employed stock trader and military/political analyst. Live in the US now, lived throughout Asia (Korea, Japan, Russia, Pakistan, India, SE asia) in the 1990s and early 2000s. Statistics and forecasting, using market based socioeconomic data, are my specialty. Sometimes I am an adjunct college professor, teaching statistics, some finance courses, and earth/environmental science classes online.
I'll try to submit SA articles from time to time but I enjoy READING the wisdom of many of you writers (thanks to many of you!). Maybe I can visit some of you along the way.